Yokohama, Japan

Tadashi Wakazawa


Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Kanazawa-ku, Yokohama-shi, Kanagawa, JP (1985)
  • Yokohama, JP (1982 - 1987)

Company Filing History:


Years Active: 1982-1987

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Tadashi Wakazawa

Introduction

Tadashi Wakazawa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of six patents to his name, Wakazawa's work has had a considerable impact on medical science.

Latest Patents

Wakazawa's latest patents include the invention of 1-oxa-1-dethia-cephalosporin compounds and an antibacterial agent. The subject invention encompasses a 1-oxa-1-dethia-cephalosporin compound represented by a specific general formula. This compound features various groups that can be modified, including methyl, ethyl, and carboxymethyl groups. Additionally, he has developed a process for the production of antibiotic 1-oxadethiacephalosporins, which involves the use of diazo-species.

Career Highlights

Throughout his career, Wakazawa has worked with prominent companies such as Merck & Company, Inc. and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Wakazawa has collaborated with esteemed colleagues, including Seiji Shibahara and Yasushi Murai. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in research and development.

Conclusion

Tadashi Wakazawa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new antibacterial agents and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…